2021
DOI: 10.1038/s41592-021-01090-x
|View full text |Cite
|
Sign up to set email alerts
|

Directed evolution in mammalian cells

Abstract: Directed evolution experiments are typically carried out using in vitro systems, bacteria, or yeast -even when the goal is to probe or modulate mammalian biology. Performing directed evolution in systems that do not match the intended mammalian environment severely constrains the scope and functionality of targets that can be evolved. We review new platforms that are now making it possible to use the mammalian cell itself as the setting for directed evolution, and present an overview of frontier challenges and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
56
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 62 publications
(56 citation statements)
references
References 104 publications
0
56
0
Order By: Relevance
“…36 AaRSs evolved in yeast may also be transferrable to other eukaryotes, albeit with potential changes in activity. 37 To the best of our knowledge, all yeast-based campaigns to identify aaRSs for ncAA incorporation have utilized the same set of positive and negative selections. Characterizations of selected aaRSs with advanced reporter systems in our group indicate that the performance of aaRSs available in yeast is highly variable, and the available OTSs cover only a limited range of chemical functionalities.…”
Section: Introductionmentioning
confidence: 99%
“…36 AaRSs evolved in yeast may also be transferrable to other eukaryotes, albeit with potential changes in activity. 37 To the best of our knowledge, all yeast-based campaigns to identify aaRSs for ncAA incorporation have utilized the same set of positive and negative selections. Characterizations of selected aaRSs with advanced reporter systems in our group indicate that the performance of aaRSs available in yeast is highly variable, and the available OTSs cover only a limited range of chemical functionalities.…”
Section: Introductionmentioning
confidence: 99%
“…The timing, location, and kinetics of these interactions are critical for the proper function of the proteins. The protein folding, post-translational modifications, localizations and interactions with other proteins are needed for performance in the cell [17].…”
Section: Discussionmentioning
confidence: 99%
“…More broadly, now that we have validated the proximity dependent split RNAP as a system to select for and evolve molecular glues, this opens up the possibility of implementing this selection scheme with other evolution technologies. For example, implementing the molecular glue selection with the yeast-based Orthorep, mammalian-based mPACE, or VEGAS systems would allow for evolution of molecules that drive the interactions between proteins that cannot be expressed in E. coli, a key limitation of PACE-based methods [70][71][72][73] . As the repertoire of rapid evolutionary technologies expands, so too will our ability to harness evolution to solve problems in synthetic biology and therapeutic design.…”
Section: Discussionmentioning
confidence: 99%
“…In the realm of PPIs, pioneering and robust directed evolution methods such as phage, mRNA, and ribosomal display technologies have generated PPIs with subnanomolar binding affinities [65][66][67] . A range of powerful continuous evolution technologies that reduce the need for human intervention, accelerate evolution, and evolve molecules in unique biological contexts have emerged, including Phage-Assisted Continuous Evolution (PACE), Orthorep, mammalian phage assisted continuous evolution (mPACE), and viral evolution of genetically actuating sequences (VEGAS) [68][69][70][71][72][73] . While powerful, all of these directed evolution approaches are limited by the selection systems that can be deployed, and a robust method to evolve molecules to drive a desired intracellular PPI is lacking.…”
mentioning
confidence: 99%